Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesOphthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent
Expert Opinion in Pharmacotherapy, 10/19/09
Jones J et al. – The comfort and reduced frequency of use offered by bromfenac would be expected to improve patient compliance, which would in turn be expected to result in adoption of bromfenac over other NSAIDs by many physicians. However, head–to–head trials comparing bromfenac with other NSAIDs using a twice–daily dosing schedule have not been undertaken. Bromfenac and other NSAIDs are seeing expanded use for the treatment and prevention of cystoid macular edema, and could have clinical utility in other diseases of vascular permeability.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacological and environmental factors in primary angle-closure glaucoma
British Medical Bulletin, 11/25/09
Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09
Article Search
Sponsor